,
by Brittany Cordeiro, NCI-CONNECT Program Supervisor
NCI-CONNECT raised consciousness for ependymoma and honored sufferers, care companions, and medical professionals in a butterfly launch occasion at NIH.
On the nice and cozy and sunny afternoon of April 18, NIH neuro-oncology professionals gathered to launch butterflies and lift consciousness for ependymoma, a uncommon central nervous system (CNS) tumor.
The butterfly is an emblem of hope chosen to signify Ependymoma Consciousness Day, a worldwide advocacy occasion held yearly since 2012 by the Collaborative Ependymoma Analysis Community (CERN) Basis, a program of the Nationwide Mind Tumor Society. Every Might, butterflies are launched at places world wide to honor individuals residing with the illness, acknowledge care companions and medical employees, and help ependymoma analysis efforts. This yr, the thirteenth Annual Worldwide Ependymoma Consciousness Day can be celebrated on Sunday, Might 5.
An estimated 1,335 persons are recognized with an ependymoma every year in the USA. The NCI-CONNECT Clinic and Neuro-Oncology Clinic at NIH see about 300 sufferers with mind or backbone tumors every year. Ependymomas are the third commonest tumor kind seen.
“We consider we see extra adults with ependymoma than some other establishment within the nation,” mentioned Terri Armstrong, Ph.D., co-leader of NCI-CONNECT and senior investigator on the NCI Heart for Most cancers Analysis’s Neuro-Oncology Department (NOB). “With the ability to have fun Ependymoma Consciousness Day at NIH with the scientific care suppliers and researchers which are making a distinction for sufferers was actually particular.”
NIH neuro-oncology professionals and CERN govt director Kimberly Wallgren (backside row, far left) gathered to launch butterflies to acknowledge Ependymoma Consciousness Day.
Credit score: NCI-CONNECT
About 35 neuro-oncology professionals, together with CERN’s govt director, Kimberly Wallgren, gathered on a patio on the NIH Scientific Heart. Attendees discovered in regards to the objective of the day and its historical past, heard poems from survivors, after which launched the butterflies.
“Ependymoma is a significant space of curiosity within the Neuro-Oncology Department and probably the most necessary uncommon CNS cancers. A lot of the seminal work accomplished in uncommon cancers has been centered on ependymoma,” mentioned Mark Gilbert, M.D., co-leader of NCI-CONNECT and chief of the NOB.
The CERN Basis was established in 2006 to enhance care and outcomes for individuals with ependymoma. Beneath the steerage of Dr. Gilbert, CERN enabled the primary potential scientific trial in grownup sufferers with ependymoma, which led to a change in therapy tips. Drs. Armstrong and Gilbert have been additionally a part of a global collaboration that found 10 new subtypes of ependymoma, displaying the necessity for extra focused remedies primarily based on a tumor’s molecular options.
“The NCI-CONNECT program was constructed following the CERN paradigm of learning a uncommon most cancers. Now, we examine over 12 uncommon cancers, together with ependymoma, as a part of NCI-CONNECT,” Dr. Gilbert mentioned.
Marta Penas-Prado, M.D., NCI-CONNECT senior clinician, was overjoyed to share the day with colleagues. “It provides me hope that we are able to come collectively to acknowledge that ependymoma—like different mind and backbone tumors—is a crucial space of analysis,” she mentioned. “There are lots of investigators working collectively to develop higher remedies.”
“At present, we work to lift consciousness of ependymomas, present group for sufferers and caregivers, and supply hope primarily based on the foundational work accomplished and being accomplished by our clinicians and researchers daily,” Dr. Armstrong mentioned.
A Celebration of Hope for the Mind and Backbone Tumor Neighborhood
